Press release
Global Tissue Heart Valves Market Projected to Grow at a CAGR of 10.08% Through 2034, According to DelveInsight
Tissue Heart Valves Market
To explore the latest developments in the Tissue Heart Valves Market, access key highlights from the report here: https://www.delveinsight.com/sample-request/tissue-heart-valves-cardiovascular-prosthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Highlights from the Tissue Heart Valves Market Report
• In September 2025, Edwards Lifesciences introduced its advanced-generation transcatheter heart valve in India for the management of aortic stenosis. This innovation offers a durable, minimally invasive option compared to traditional open-heart surgery, particularly benefiting patients across the Asia-Pacific region. The launch underscores the rising uptake of TAVR technologies in emerging economies.
• The global Tissue Heart Valves market is anticipated to expand from USD 10,743.75 million in 2025 to USD 25,307.93 million by 2034, demonstrating robust growth potential.
• The market is forecasted to grow at a CAGR of 10.08% during the period 2026-2034.
• North America is expected to maintain its leading position due to the increasing prevalence of valvular heart disorders, strong adoption of advanced procedures like TAVR, and the presence of major industry players. Supportive reimbursement frameworks, advanced healthcare infrastructure, and a growing aging population further strengthen the region's dominance.
• Prominent companies operating in the Tissue Heart Valves Market include Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic, LivaNova PLC (Sorin Group), Braile Biomédica, Labcor Laboratórios, Colibri Heart Valve, ON-X Life Technologies, JenaValve Technology Inc., TTK Healthcare Limited, Comed BV, Meril Life Sciences, Beijing Balance Medical Technology Co., Venus Medtech, and others.
To understand the factors driving North America's leadership in the market, access insights here: https://www.delveinsight.com/sample-request/tissue-heart-valves-cardiovascular-prosthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Tissue Heart Valves Market Dynamics
The growing burden of valvular heart diseases is a major factor propelling demand for tissue heart valves. Recent studies (2026) indicate that aortic stenosis remains the most prevalent valvular condition in developed nations, impacting nearly 10% of individuals aged above 75 years, with approximately 2-4% suffering from severe disease. Notably, about half of the affected population remains asymptomatic at diagnosis.
According to DelveInsight (2026), the prevalence of aortic stenosis among individuals aged 75 and above is estimated at 12.4%, with 3.4% experiencing severe forms, based on studies primarily conducted in Europe and the US. Disease progression leads to narrowing of the aortic valve, restricting blood flow and often necessitating valve replacement in moderate-to-severe cases. The increasing adoption of minimally invasive procedures such as TAVR, which utilize bioprosthetic valves, is significantly boosting procedural volumes globally.
AI-Driven Advancements and Applications
Artificial intelligence is transforming both the design and clinical utilization of tissue heart valves. Advanced machine learning techniques analyze large datasets from imaging and biomechanical studies to optimize valve structures that closely replicate natural heart function and minimize stress-induced damage.
AI-powered simulation tools enable virtual testing of valve prototypes under diverse physiological conditions, accelerating innovation while reducing reliance on physical trials. Clinically, AI supports personalized treatment decisions by integrating patient-specific anatomical data, imaging results, and risk profiles, helping clinicians determine optimal valve selection and sizing for improved outcomes.
Tissue Heart Valves Market Segmentation Analysis
The market is segmented based on type (stented, stentless, and sutureless), valve position (aortic, mitral, pulmonary, and tricuspid), end users (hospitals, ambulatory surgical centers, and cardiac specialty centers), and geography (North America, Europe, Asia-Pacific, and Rest of the World).
However, the market faces certain challenges. Bioprosthetic valves have limited durability and are susceptible to degeneration and calcification over time, especially in younger patients, increasing the likelihood of repeat interventions. Additionally, the high cost of procedures like TAVR limits accessibility in developing and cost-sensitive regions. Strict regulatory requirements, including extensive clinical trials and long-term safety validation, further delay product approvals and increase development costs, collectively restraining market growth.
Explore more insights on market dynamics here: https://www.delveinsight.com/sample-request/tissue-heart-valves-cardiovascular-prosthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Tissue Heart Valves Competitive Landscape
The Tissue Heart Valves Market features a mix of established global leaders and emerging regional players, creating a moderately consolidated yet competitive environment. Major companies such as Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific dominate the space with diverse portfolios of surgical and transcatheter valves across various applications.
These organizations leverage strong research capabilities, extensive clinical validation, global distribution networks, and early regulatory approvals to secure leading positions, particularly in developed markets like North America and Europe.
Tissue Heart Valves Companies
Key players in the market include Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic, LivaNova PLC, Braile Biomédica, Labcor Laboratórios, Colibri Heart Valve, ON-X Life Technologies, JenaValve Technology Inc., TTK Healthcare Limited, Comed BV, Meril Life Sciences, Beijing Balance Medical Technology Co., Venus Medtech, and others.
Tissue Heart Valves Market Drivers
The growth of the Tissue Heart Valves Market is primarily fueled by the rising incidence of valvular heart diseases, including aortic stenosis and mitral regurgitation, along with the expanding adoption of transcatheter procedures such as TAVR.
An increasing elderly population, which often prefers tissue valves due to the reduced need for long-term anticoagulation therapy, further supports market expansion. Continuous technological advancements aimed at improving durability and enabling minimally invasive and valve-in-valve procedures are also accelerating global adoption.
Discover leading MedTech players shaping the market: https://www.delveinsight.com/sample-request/tissue-heart-valves-cardiovascular-prosthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Tissue Heart Valves Market Report
• Coverage: Global
• Forecast Period: 2026-2034
• Key Companies: Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic, LivaNova PLC, Braile Biomédica, Labcor Laboratórios, Colibri Heart Valve, ON-X Life Technologies, JenaValve Technology Inc., TTK Healthcare Limited, Comed BV, Meril Life Sciences, Beijing Balance Medical Technology Co., Venus Medtech, and others
Interested in future market trends? Access insights here: https://www.delveinsight.com/sample-request/tissue-heart-valves-cardiovascular-prosthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Tissue Heart Valves Market Introduction
2. Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Key Factors Analysis
6. Porter's Five Forces Analysis
7. Market Assessment
8. Company and Product Profiles
9. KOL Insights
10. Project Methodology
11. About DelveInsight
12. Disclaimer & Contact Information
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Tissue Heart Valves Market Projected to Grow at a CAGR of 10.08% Through 2034, According to DelveInsight here
News-ID: 4456972 • Views: …
More Releases from DelveInsight Business Research
Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Retinitis Pigmentosa pipeline constitutes 20+ key companies continuously working towards developing 25+ Retinitis Pigmentosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Retinitis Pigmentosa Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Retinitis Pigmentosa Market.
The Retinitis…
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Dr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Car T Cell Therapy For Multiple Myeloma Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into…
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
More Releases for Valve
Selecting the Right Valve: Knife Gate Valve vs. Wedge Gate Valve
Choosing between a knife gate valve and a wedge gate valve isn't just about picking a piece of metal for your pipeline. It's about preventing costly downtime. Get it wrong, and you are looking at clogged lines, seat erosion, or total system failure. While both valves serve as isolation devices, they operate on completely different mechanical principles.
At Tianjin Guoji Valve Co., Ltd. (widely recognized in the industry as TGV), we…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;…
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure.
According to Fact.MR’s…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which…
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn…
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market…
